Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer-Reference-Cited by-同舟云学术

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer

Published:2020-12-07 Issue:1 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Lu Weiqiang¹^ORCID,Yu Weiwei¹,He Jiacheng¹,Liu Wenjuan¹,Yang Junjie¹,Lin Xianhua¹,Zhang Yuanjin¹,Wang Xin¹^ORCID,Jiang Wenhao¹,Luo Jian¹,Zhang Qiansen¹,Yang Huaiyu¹,Peng Shihong¹,Yi Zhengfang¹,Ren Shancheng²,Chen Jing³,Siwko Stefan⁴,Nussinov Ruth⁵⁶,Cheng Feixiong⁷⁸⁹,Zhang Hankun¹^ORCID,Liu Mingyao¹^ORCID

Affiliation:

1. Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Shanghai China

2. Department of Urology Changhai Hospital Second Military University Shanghai China

3. School of Basic Medical Sciences Ningxia Medical University Yinchuan China

4. Department of Molecular and Cellular Medicine Institute of Biosciences and Technology Texas A&M University Health Science Center Houston TX USA

5. Cancer and Inflammation Program Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute Frederick MD USA

6. Department of Human Molecular Genetics and Biochemistry Sackler School of Medicine Tel Aviv University Tel Aviv Israel

7. Genomic Medicine Institute, Lerner Research Institute Cleveland Clinic Cleveland OH USA

8. Department of Molecular Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland OH USA

9. Case Comprehensive Cancer Center Case Western Reserve University School of Medicine Cleveland OH USA

Funder

National Natural Science Foundation of China

Shanghai Municipal Education Commission

Shenzhen Graduate School, Peking University

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202012798

Reference63 articles.

1. EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity

2. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis

5. The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review);International Journal of Oncology;2024-07-25

2. Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells;Neoplasia;2024-07

3. Multi‐synergistic chemotherapeutic drug assemblies to activate colorectal cancer immunotherapy by modulating the multilevel immunosuppressive characteristics;Aggregate;2024-06-26

4. Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer;ACS Nano;2024-06-03

5. Immunosuppressive regulatory cells in cancer immunotherapy: restrain or modulate?;Human Cell;2024-05-30